Short description
Dicerna Pharmaceuticals is a biotechnology company with a focus on the development of innovative treatments for rare inherited diseases.
Description
Dicerna Pharmaceuticals is a biotechnology company involved in the discovery and development of innovative treatments for rare inherited diseases affecting the liver, along with cancers, and other therapeutic areas to address liver problems. It is using ribonucleic acid interference (RNA) technology platform to develop its products. The product candidates are DCR-PHXC (for primary hyperoxaluria), DCR-undisclosed (for orphan genetic disease), DCR-PCSK9 (for cardiovascular disease), and DCR-HBV (for hepatitis B virus) among others.
The company was founded in 2007 and is headquartered in Lexington, Massachusetts.
Last funding
Noaccessforu
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Lexington, Massachusetts, United States, North America
Founded on
January 1, 2007
Closed on
November 18, 2021
Exited on
January 31, 2014
Went public on
January 31, 2014
Stock symbol
DRNA
Non-profit?
No
Acquired?
No
Employees count
251-500
Revenue range
$34056 - 789030
Sign in for full access
Investors
Cannot Access, Blurry Noaccess, Cannot Access, Noway Youcantaccess, Cannot Access, Nopepepe, Noaccessforu, Noway Youcantaccess, Cannot Access, Blurry Noaccess, Uh Ohhhh, Noaccess, Absolutely Noaccess, No Way, Nopepepe
Sign in for full access
Founders
James Jenson, Jim Jenson